A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...

A groundbreaking drug has nearly doubled survival rates for pancreatic cancer patients, offering new hope in the fight ...

Ukraine war, China’s rare earth controls and the Iran turmoil risk hurting a promising corner of the $280 billion ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

A novel immunotherapy could lead to a brain cancer breakthrough after showing promising results against glioblastoma, the ...

Learn more about Cancer Research UK's Unlock Cancer Breakthroughs campaign and help call on governments to remove the barriers holding back research.

In the study, patients taking the drug lived longer compared to those undergoing chemotherapy. "This study showed that they doubled that. They went from 6.5 to like 13 months on average," Dr. Zev ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Researchers have unveiled a breakthrough showing that a subset of ...

Earlier diagnosis of bowel cancer is the promise of using artificial intelligence to analyse people's gut to predict whether ...